Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs

NCT01436929 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Silymarin
DRUG: Placebo

Sponsor

Seoul National University Hospital